Determination of pholcodine alone or in combination with ephedrine in human plasma using fluorescence spectroscopy

• Published in: Scientific reports Vol. 12; no. 1; p. 9372
• Main Authors: Elmansi, Heba, Belal, Fathalla, Magdy, Galal
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 07-06-2022; Nature Publishing Group; Nature Portfolio
• Subjects: 639/638; 639/638/11; Acids; Analytical chemistry; Chromatography; Codeine - analogs & derivatives; Detection limits; Drug abuse; Drug dosages; Ephedrine; Fluorescence; Fluorescence spectroscopy; Humanities and Social Sciences; Humans; Methods; Morpholines; multidisciplinary; Pharmaceuticals; Pharmacy; Plasma; Quantitation; Science; Science (multidisciplinary); Sodium; Solvents; Spectrometry, Fluorescence - methods
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-022-13194-1

In this study, sensitive, facile, and cost-effective spectrofluorimetric approaches were developed for the determination of pholcodine and ephedrine. Method I is a novel spectrofluorimetric method depending on measuring the native fluorescence of pholcodine at 337 nm after excitation at 284 nm over a concentration range of 0.01–2.4 μg/mL. The method sensitivity reached quantitation and detection limits down to 10.0 and 5.0 ng/mL, respectively. Method II relied on the simultaneous estimation of pholcodine and ephedrine using synchronous fluorimetry for the first time. The cited drugs were measured concurrently at 286 and 304 nm for pholcodine and ephedrine, respectively at Δλ of 40 nm without interference. Excellent linear relationship between concentration and response was obtained over the ranges of 0.05–6.0 μg/mL and 0.02–1.0 μg/mL for pholcodine and ephedrine, respectively. The method showed distinct sensitivity and exhibited quantitation limits of 20.0 and 10.0 ng/mL and detection limits of 10.0 and 5.0 ng/mL, respectively. The method was successfully applied to the syrup dosage form. The two developed approaches were also applied to in-vitro plasma samples, showing good bioanalytical applicability and providing further insights for monitoring drug abuse. The proposed methods were validated according to ICHQ2(R1) guidelines. The proposed methodologies' greenness profiles were evaluated using two greenness assessment tools.